Contact: Roy Janson
[email protected]

TO: 2015 Lucas Oil Pro Motocross Competitors and Crew Members

FROM: MX Sports Pro Racing

DATE: May 8, 2015

RE: COMP. BULLETIN 2015-3:                       

USADA to Conduct Anti-Doping Testing For 2015 Series and Anti-Doping Seminar at Hangtown National

MX Sports Pro Racing has renewed its agreement with the United States Anti-Doping Agency (USADA) to implement and administer the anti-doping program for athletes competing in the 2015 Lucas Oil Pro Motocross Championship, in compliance with the World Anti-Doping Code (Code).  As a result, USADA representatives will again be conducting anti-doping testing at 2015 series events. 

Furthermore, MX Sports Pro Racing will be hosting a second Anti-Doping Seminar at the upcoming Hangtown Motocross Classic next Friday, May 15, 2015, from 3 PM.  Mike Thompson, a representative from the United States Anti-Doping Agency (USADA), will be in attendance to review the 2015 WADA Code and pertinent changes, and to field questions from riders and crew members, along with representatives from MX Sports Pro Racing.  The meeting will be conducted at the Prairie City OHV Park in Rancho Cordova, CA, in the Media Center in the Paddock.  All intended 2015 Lucas Oil Pro Motocross competitors are encouraged to attend.

Primary points for discussion will be:

• Renewal of USADA to serve as the independent sample collection and results management provider for the 2015 Series
• Requirement and process for obtaining Therapeutic Use Exemptions (TUE) and the 21-day approval process
• Reminder that a TUE issued by FIM for AMA Supercross is NOT valid for Pro Motocross
• Requirement that riders currently enrolled or who have ever been enrolled in a Registered Testing Pool for USADA or FIM obtain a TUE in advance of testing
• Difference between National and Non-National status athletes for testing purposes
• Explanation of the Global Drug Reference Online available www.globaldro.org
• Use of Supplements and associated testing concerns

All competitors and associated team representatives are strongly encouraged to become clearly familiar with USADA and its substance testing policies and protocols at www.usada.org, and with the Code which is also available on the USADA website.

Athletes may be selected for urine and/or blood testing, and the samples may be tested in accordance with the World Anti-Doping Agency (WADA) Prohibited List http://www.usada.org/substances/prohibited-list/.

Athletes can find full details about both the blood and urine collection procedures at http://www.usada.org/testing/.

As athletes are responsible for any substance they ingest, it is very important that athletes check the prohibited status of any medication they are using. USADA has created an easy to use resource at http://www.globaldro.org which is a mobile enabled website that allows athletes to search the status of their medications. If an athlete has any additional questions regarding the status of a medication or substance, they can call719.785.2000 (option 2) to speak to the Drug Reference Line.

If a medication is prohibited at all times or only in-competition, and the athlete has a legitimate medical need to take that substance, they can apply for a Therapeutic Use Exemption (TUE). Athletes should review the TUE process at www.usada.org/tue or contact USADA at [email protected] or by phone at 719.785.2000.

Furthermore, in accordance with the WADA Prohibited List (Category M2 Chemical and Physical Manipulation), all intravenous infusions and/or injections of more than 50mL (~3.4 tablespoons) per 6-hour period are prohibited, except for those legitimately received in the course of hospital admissions, surgical procedures or clinical investigations. This supersedes any rule regarding Intravenous Hydration in the AMA Pro Motocross Rulebook.  Intravenous infusions and/or injections above 50mL per 6-hour period are prohibited at all times, both in- and out-of-competition without an approved TUE.

Finally, riders are cautioned to be sure that any dietary supplements that they may take, in any form (powder, liquid, tablet, capsule, spray, etc.) and by any route of administration must be in compliance with the WADA Prohibited List. USADA provides information on the risks associated with using supplements at http://www.usada.org/substances/supplement-411/.

For further questions, please contact Roy Janson @ [email protected].